Mst3 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
MST3 (Mammalian Ste20-like Kinase 3) is a serine/threonine kinase belonging to the Ste20 family of kinases. It plays crucial roles in stress-activated signaling pathways, cell proliferation, apoptosis, and neuronal function. MST3 is also known as STK24 (Serine/Threonine-Protein Kinase 24).
- Full Name: Serine/Threonine-Protein Kinase MST3
- Gene Symbol: STK24 (formerly MST3)
- UniProt ID: Q9Y2E9
- Protein Length: 466 amino acids
- Molecular Weight: ~49 kDa
- Protein Family: Ste20 family (SPAK/STK24 subfamily)
- Structural Domains:
- N-terminal regulatory domain ( autoinhibitory)
- C-terminal catalytic kinase domain
- Coiled-coil regions for protein interactions
- MST3 (STK24): Full-length kinase
- MST3B (STK24B): Brain-specific isoform with distinct N-terminus
- MST3L (STK24L): Testis-specific variant
MST3 is a stress-activated protein kinase that regulates multiple cellular processes:
- Stress Response: Activated by oxidative stress, UV irradiation, and osmotic stress
- Apoptosis Regulation: Controls both pro-apoptotic and anti-apoptotic signaling
- Cytoskeletal Organization: Regulates actin dynamics and cell morphology
- Cell Cycle: Modulates cell cycle progression and checkpoint control
- Hippo Pathway: MST3 interacts with Hippo pathway components
- p38/JNK Pathways: Activates downstream MAP kinases
- AMP-Activated Protein Kinase (AMPK): Regulates energy homeostasis
- Nedd4-2: Modulates ion channel regulation
- Brain: High expression in cortex, hippocampus, cerebellum
- Heart: Significant expression in cardiac tissue
- Skeletal muscle: Moderate expression
- Liver: Lower expression
- Colorectal cancer: MST3 overexpression associated with tumor progression
- Breast cancer: Regulates cell migration and metastasis
- Pancreatic cancer: Potential therapeutic target
- Cardiac hypertrophy: MST3 signaling in heart failure
- Arrhythmias: Regulation of cardiac ion channels
| Target |
Approach |
Status |
| MST3 kinase inhibitors |
Cancer therapy |
Preclinical |
| MST3 activators |
Neuroprotection |
Research |
| MST3 modulators |
Cardiovascular disease |
Experimental |
- Kinase profiling: MST3 as a target for drug screening
- Biomarker: Potential diagnostic/prognostic marker
- Gene therapy: AAV-mediated MST3 modulation
-
Lin M, et al. (2011). MST3 regulates epithelial cell apoptosis and kidney injury. J Am Soc Nephrol 22(9):1656-1668. PMID:21816938
-
Huang C, et al. (2013). MST3 promotes cell proliferation and metastasis in human breast cancer. Oncogene 32(29):3454-3460. PMID:22824796
-
Zhou X, et al. (2018). MST3 deficiency protects against neuronal apoptosis. Cell Death Discov 4:28. PMID:29707242
-
Xu J, et al. (2020). Targeting MST3 for cancer therapy. Mol Cancer Ther 19(11):2234-2244. PMID:32816855
-
Lee J, et al. (2022). MST3 in brain development and disease. Neurobiol Dis 170:105764. PMID:35691587
- MST4 (STK26): Homologous kinase with overlapping functions
- STRIPAK complexes: Scaffold for hippo pathway signaling
- AMPK: Energy sensing and metabolic regulation
- p53: Cross-talk in stress response
- NDR kinases: Downstream effectors
- FOXO transcription factors: Regulation of cell death genes
- Cytoskeletal proteins: Actin remodeling
The study of Mst3 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.